Objective To investigate the clinical factors, including intravascular ultrasound (IVUS) findings, associated with percutaneous coronary intervention (PCI)-related periprocedural myonecrosis (PM) in patients with stable coronary artery disease (CAD). Methods The study included 46 patients (mean age 65±2 y, 37 men) with stable CAD who underwent elective PCI using IVUS and a Doppler flow guidewire. In addition to routine IVUS measurements, the presence of deep echo attenuation (DEA) without calcification was assessed. The sum of all high-intensity transient signals (HITS) after a balloon deflation procedure was calculated using a Doppler flow guidewire. PM was defined as an elevation in troponin T to >0.03 ng/mL 24-hour after PCI. Patients were divided into 2 groups on the basis of the presence or absence of PM. Results PM was identified in 17 patients (37%). Estimated glomerular filtration ratio was lower in the PM group (p=0.021). Target vessel distribution was different between the groups (p=0.004). Positive remodeling and DEA, as observed on IVUS, were more common in the PM group (p=0.03 and p<0.0001, respectively). The total number of HITS was higher in the PM group (p=0.003). Logistic regression analysis demonstrated that the presence of DEA (p=0.003) was the sole factor associated with the occurrence of PM. Conclusion These results demonstrated that DEA is an important factor associated with PM in patients who underwent an elective PCI. Therefore, IVUS to determine the presence of DEA should be performed before PCI.
Introduction
with several other factors (4, (6) (7) (8) . Recent studies using intravascular ultrasound (IVUS) have reported that lesions exhibiting deep echo attenuation (DEA) without calcification were associated with distal embolization, which leads to the occurrence of PM, particularly in patients with acute coronary syndrome (ACS) (7, 8) . However, lesions exhibiting DEA have also been observed in patients with stable CAD (9) , but only a few studies have reported whether elective PCI for these lesions causes PM in such patients (10) . Therefore, to clarify the relationship between DEA and PM, we investigated the biochemical, angiographic, IVUS and intracoronary Doppler flow parameters including highintensity transient signals (HITS), which can detect small embolic particles (11) (12) (13) (14) in 46 CAD patients who underwent elective PCI.
Materials and Methods

Study population
The study included 49 consecutive Japanese patients (mean age 65±2 y, 39 men) with CAD who underwent PCI using IVUS and a Doppler flow guidewire. The inclusion criteria were as follows: 1) single de novo target lesion of the native coronary artery, 2) reference lumen diameter of the target lesion greater than 2.5 mm; lesion length less than 35 mm and 3) successful PCI with residual stenosis of less than 25% as observed on angiography. The exclusion criteria were as follows: 1) ACS including acute myocardial infarction (AMI) requiring emergency PCI, 2) unstable hemodynamics or heart failure, 3) suboptimal results such as coronary dissection or side branch occlusion, 4) complex lesions such as chronic total occlusion, severe calcified lesions or bifurcated lesions requiring kissing balloon technique, and 5) requirement of intra-aortic balloon pumping during PCI, which may affect the levels of biomarkers for myocyte injury. The study protocol was approved by the Ethics Committee of Hiroshima University Hospital and written informed consent was obtained from all patients. Among the forty-nine patients, IVUS catheter did not cross the target lesion in one patient and the Doppler flow guidewire did not cross the target lesion in one patient. Another patient required intra-aortic balloon pumping during PCI. Therefore, the final study sample comprised 46 patients (mean age 65± 2 y, 37 men).
To examine the influence of PM on treatment outcomes, the period from PCI to hospital discharge was investigated for each patient because the period from admission to PCI was variable. In addition, cardiovascular events during hospitalization and for 6 months after discharge were recorded.
Study protocol
Each patient was administered 100 mg aspirin and 200 mg ticlopidine or 75 mg clopidogrel at least 2 days before PCI. Intravenous heparin (5,000 U) was routinely administered after insertion of the sheath and additional heparin was administered on the basis of the measured activated clotting time. PCI consisted of the following processes: A 6-or 7-Fr guide catheter was inserted, and angiography was performed. A 0.0014-inch Doppler flow guidewire (Volcano FloWire; Volcano Therapeutics Inc., Rancho Cordova, CA) was used. If the Doppler flow guidewire did not cross the stenotic lesion or was predicted not to do so, a standard guidewire was used as the first guidewire and was then changed to the Doppler flow guidewire using a microcatheter. Next, IVUS observation and plain old balloon angioplasty (POBA) were performed using a standard balloon. The size and length of the balloon used were determined on the basis of angiographic and IVUS findings. The inflation time for each balloon was 30 seconds. A second POBA was performed according to the operator's judgment. Next, a coronary stent was implanted. Additional POBA was performed if optimal results were not obtained in accordance with angiographic and/or IVUS findings. A final IVUS observation was performed and several angiograms were obtained after the procedure was considered complete.
Quantitative coronary angiography (QCA) and angiographic parameters
After the intracoronary administration of 0.2 mg nitroglycerin, the target lesion was assessed before and after PCI. Angiograms were recorded at 15 frames/s and the images were obtained using an automated-injection system (Zone Master, Sugan Co., Ltd., Osaka, Japan) with nonionic lowosmolar contrast agents. Coronary parameters were measured without knowledge of the clinical characteristics of patients. The end-diastolic frame was selected, and images were analyzed using a computer-assisted coronary angiographic analysis system (CMS-QCA system; Medis Medical Imaging Systems, Leiden, The Netherlands) (15, 16) . The average values of the 3 measurements of the following parameters were used for analysis: the reference lumen diameter, minimal lumen diameter, lesion length, and percent stenosis before and after PCI. The morphology of the target lesion was described using the American Heart Association/ American College of Cardiology (AHA/ACC) classification (17) . Angiographic slow flow was defined as a profound reduction in antegrade coronary blood flow [Thrombolysis in Myocardial Infarction (TIMI) flow grade !2] despite vessel patency. In addition, the corrected TIMI frame count (CTFC) was assessed by final coronary angiography after PCI, as previously reported (18) .
IVUS
IVUS (40MHz; Atlantis Pro2; Boston Scientific, Natric, MA) was performed before and after intervention with the automated pullback system (0.5 mm/s). Serial IVUS images were digitized and stored on the hard disk of the IVUS console. Using the IVUS analysis system (echoPlaque 2; IN-DEC Medical System, Santa Clara, CA), the morphometric parameters of the external elastic membrane (EEM) crosssectional area (CSA) and lumen CSA were measured as pre- viously described (19) . Plaque plus media (P + M) CSA was calculated as EEM CSA minus lumen CSA, and plaque burden was calculated as P + M CSA divided by EEM CSA ×100. In some of the patients, it was difficult to identify EEM in lesions with DEA, and the EEM-CSA and plaque burden of such lesions were not accurate. In such cases, planimetry of the circumference was performed by extrapolation from the closest identifiable EEM borders. The remodeling index was defined as the lesion site EEM CSA divided by mean reference segment EEM CSA. Positive remodeling was defined as a remodeling index of greater than 1.0 (19) . DEA was defined as a reduction in the amplitude of the ultrasound beam as a function of distance through the imaging medium (8, 20) . Attenuated plaque definition required the agreement of 2 independent, experienced observers (H.T. and K.N.). Calcification was identified by extremely bright echoes (brighter than the adventitia) with acoustic shadowing of deeper tissue zones. Representative IVUS images are shown in Fig. 1 .
Doppler flow measurement
The tip of the Doppler guide wire was placed approximately 2-3 cm distal to the target lesion and the coronary blood flow velocity (CBFV) spectrum was monitored with an attached apparatus (FloMap; Volcano Therapeutics, Rancho Cordova, CA) and recorded continuously on videotape throughout subsequent PCI. HITS were determined on the basis of the following previously described criteria (21): 1) visual high-intensity signals, and 2) unidirectional signals within the advancing velocity spectrum apart from the baseline. HITS usually appeared within several beats after balloon deflation, and the CBFV spectrum was monitored from 2 seconds before to 30 seconds after balloon deflation. The sum of all HITS after balloon deflation was calculated for all patients. Moreover, the coronary flow reserve (CFR), which was defined as the ratio of CBFV after intracoronary infusion of 20 μg adenosine triphosphate relative to the baseline value, was assessed immediately after PCI, in some patients (n=26).
Biochemical markers and assessment of coronary risk factors
Blood samples before and 24 hours after PCI were collected and cardiac troponin T (cTnT), creatinine kinase (CK), CK-MB fraction (CK-MB) and high sensitive Creactive protein (CRP) levels were measured. A sensitive and precise third-generation assay (Troponin T III STAT; Roche Diagnostics, Indianapolis, IN) was performed with a normal upper limit of 0.01 ng/mL. According to the definition of PM following PCI, PM was defined as the presence of cTnT levels greater than 0.03 ng/mL after PCI (22) . The patients were divided into 2 groups on the basis of the presence or absence of PM (PM and non-PM groups, respectively).
Each patient was questioned about their smoking status and classified as a current smoker, past smoker (who had stopped smoking for at least a month), or non-smoker. Blood pressure was measured and hypertension was confirmed if the patient had a blood pressure of greater than or equal to 140/90 mmHg and/or was on antihypertensive medication. In addition, blood chemical parameters such as total cholesterol, triglyceride, high-density lipoprotein cholesterol, fasting blood sugar (FBS), hemoglobin A1C (HbA1 C), and creatinine levels were also measured. Low-density lipoprotein (LDL) cholesterol was calculated using the Friedewald equation (23) . Hyperlipidemia was defined as having an LDL cholesterol of greater than or equal to 120 mg/dL and/or was on medication for the same. Diabetes mellitus (DM) was defined as an FBS of greater than or equal to 126 mg/dL and/or HbA1C of greater than or equal to 6.5% and/ or was on medication for either of the two. The presence of metabolic syndrome was determined according to the final report of the National Cholesterol Education Program Adult Treatment Panel III criteria (24) . The estimated glomerular filtration rate (eGFR; mL/min/1.73 m 2 ) was calculated using the revised equations suggested in Japan for obtaining eGFR 
Statistical analyses
All data were expressed as the mean ± SEM. Baseline characteristics of the 2 groups were compared using Student's unpaired t-test or a chi-squared analysis, as appropriate. Spearman's rank correlation was used to investigate the relationship between total HITS and cTnT levels after the procedure. Logistic regression analysis was performed to identify the independent predictors responsible for the presence of PM. This model included the parameters that were significantly correlated in the univariate analysis. A p value of less than 0.05 was considered statistically significant.
Results
Patient characteristics and blood chemical parameters
Of the 46 patients, PM was identified in 17 (37%). Baseline patient characteristics are shown in Table 1 . The presence of CKD tended to be higher in the PM group than in the non-PM group, and the left ventricular ejection fraction, as evaluated by echocardiography, tended to be lower in the PM group than in the non-PM group.
The blood chemical parameters are shown in Table 2 . Total cholesterol levels tended to be higher, whereas eGFR was lower, in the PM group than in the non-PM group. Baseline levels of CRP, CK, and CK-MB were not significantly different between the 2 groups. However, cTnT, CK, and CK-MB levels after PCI were significantly higher in the PM group than in the non-PM group; however, the difference was significant only for CK-MB (p=0.006). CRP levels remained comparable between the 2 groups.
PCI-related parameters and outcomes
The procedure of PCI, including the inflation time (PM group, 2.9±0.2; non-PM group, 2.7±0.1), the total inflation duration (PM group, 88±6 s; non-PM group, 79±4 s) and maximum inflation pressure (PM group, 16±1 atm; non-PM group, 16±1 atm), was similar between the 2 groups. The average stent size (PM group, 3.2±0.1 mm; non-PM group, 3.3±0.1 mm) and length (PM group, 21.2±1.2 mm; non-PM, 18.8±1.0 mm) were similar between the 2 groups. The frequency of use of a drug-eluting stent (PM group, 76%; non-PM group, 69%) was similar between the 2 groups. The period from PCI to hospital discharge was longer in the PM group (4.2±0.6 days) than in the non-PM group (2.4±0.5 days; p=0.028). During hospitalization, none of the patients experienced cardiovascular events after PCI. Two patients (12%) in the PM group died, 1 from heart failure 4 months after PCI and 1 from cerebral bleeding 2 months after PCI; however, there were no deaths in the non-PM group (p= 0.059).
Angiographic, IVUS and Doppler flow data
With regard to the target vessels, there were 7 left anterior descending coronary artery (LAD), 6 left circumflex coronary artery (LCX), and 4 right coronary artery (RCA) lesions in the PM group, whereas there were 14 LAD, 1 LCX, and 14 RCA lesions in the non-PM group. Therefore, target vessel distribution differed between the 2 groups (p= 0.011). The number of AHA/ACC-type B2/C lesions did not differ between the 2 groups (PM group, 9 lesions; 53% vs. non-PM group, 12 lesions; 41%, p=0.447). QCA data are presented in Table 3 . There were no significant differences in the angiographic lesion characteristics before and after PCI. Angiographic slow flow during PCI was observed in the PM group (n=2, 12%), but not in the non-PM group (p= 0.059). CTFC obtained from the final angiogram of the PCI procedure tended to be higher in the PM group than in the non-PM group (p=0.098). IVUS revealed that the lumen CSA, external CSA, and plaque burden were not significantly different between the 2 groups ( Table 3 ). The frequency of positive remodeling was higher in the PM group than in the non-PM group (p=0.03). In addition, the frequency of DEA was significantly higher in the PM group than in the non-PM group (p<0.0001). There was mild but non-significant relationship between the presences of positive remodeling and DEA on IVUS (p= 0.051).
The total number of HITS during PCI was higher in the PM group than in the non-PM group (p=0.001). The total number of HITS was positively correlated with cTnT levels after PCI (ρ=0.593; p<0.0001, Fig. 2 ). The presence of DEA was correlated with an increased total number of HITS (DEA+: 11±1, DEA-: 2±1, p<0.0001) but the presence of positive remodeling was not correlated with the total number of HITS (positive remodeling+: 5±2, positive remodeling-: 5±1, p=0.829). CFR after PCI was lower in the PM group (n=10, 2.6±0.1) than in the non-PM group (n=16, 2.8±0.1, p=0.039).
Factors associated with PM
Univariate analyses revealed that eGFR, target vessel distribution, and the presence of positive remodeling and DEA on IVUS were associated with PM. Logistic regression analysis revealed that the presence of DEA on IVUS was the sole factor associated with the occurrence of PM (Table 4).
Discussion
In the present study, we focused on the factors associated with PM in patients with stable CAD treated by elective PCI. Our results revealed that reduced renal function, target vessel distribution, and the presence of positive remodeling and DEA on IVUS were associated with PM. Furthermore, logistic regression analysis demonstrated that the presence of DEA on IVUS was the sole factor associated with the occurrence of PM in such patients.
Several papers have reported the effect of PM after PCI on patient prognosis (2, 3, 5) . For example, Fuchs et al (2) reported an increased risk of major events in hospitalized patients who were troponin-positive after PCI. In addition, Prasad et al (5) showed that PM was associated with increased short-term mortality (within 30 days after PCI), but not long-term mortality. According to these reports (2, 3, 5), PM is undoubtedly one of the factors responsible for shortterm mortality after PCI. In the present study, none of the patients with PM had any major cardiovascular events immediately after PCI. Within 6 months after PCI, however, 2 patients with PM died, although 1 of these deaths was due to cerebral bleeding. Therefore, our results did not indicate a higher incidence of cardiovascular events in patients with PM after PCI; however, these patients were hospitalized for a longer duration than those without PM. Additional precautions are therefore required to prevent PM in patients who undergo elective PCI. To prevent the occurrence of PM, it is essential to understand the factors responsible for it, particularly those that are patient-and/or lesion-related. Several patient-related factors are reportedly associated with PM (4, (6) (7) (8) ; however, the present results indicated that patient-related factors were comparable between the 2 groups, except for eGFR. CKD reportedly influences coronary plaque composition (26) , and recent research has focused on the relationship between CKD and PM. However, we could not demonstrate the precise relationship between reduced eGFR and PM by logistic regression analysis; this may be because of the small sample size. Therefore, further observation is necessary to elucidate this potential relationship.
Some lesion-related factors associated with PM, such as the presence of a thrombus or complex lesions (6), have been reported, but we did not observe any differences in angiographic parameters other than target vessel distribution between the 2 groups. As per the logistic regression analysis, lesions in the LCX were not associated with PM. The present study included only a small number of patients with LCX lesions; therefore, we could not reach a definitive conclusion on this issue. Further observation of this relationship is necessary. However, we did demonstrate that the presence of DEA on IVUS was associated with PM, and this was accompanied by an increase in the total number of HITS as an index of distal embolization.
The exact pathology of DEA remains unclear. Lee et al (8) analyzed 293 patients with ACS and found that DEA was more common in patients with ST-elevation myocardial infarction (STEMI) than in those with non-STEMI, and the presence of DEA on IVUS was associated with higher CRP levels in patients with ACS. Using histological evaluation by IVUS, Yamada et al (27) reported that plaque with DEA contains more fibrofatty tissue and necrotic core than does plaque without DEA. These findings revealed that DEA may indicate plaque vulnerability; however, patients with ACS were not included in the present study. Furthermore, Hara et al (28) reported an autopsy specimen with DEA that had Von Kossa-positive granules within a fibrous plaque, indicating that attenuation may be caused by the presence of microcalcification. In the present study, no significant difference was observed in plaque burden between the 2 groups. The presence of an acoustic shadow in the EEM at the site of DEA made calculation of the EEM-CSA difficult in some patients. Therefore, despite the lack of a significant difference in plaque burden, we cannot rule out the presence of a considerable amount of plaque in the lesions with DEA. Altogether, DEA may indicate vulnerable properties with microcalcification and large plaque volumes, because of which PCI could cause distal embolization and, eventually, PM.
The present study demonstrated that the presence of DEA was the sole significant factor associated with PM, even in patients with stable CAD treated by elective PCI. Recent studies have shown that the use of statins reduced the frequency of PM in patients undergoing elective PCI (29, 30) . In the present study, the use of a statins did not influence the occurrence of PM, but we did not analyze the relationship between dose and duration of treatment and the occurrence of PM because of the small number of patients. Therefore, when a lesion shows DEA, deferring PCI until the patient can be treated with statins to stabilize the lesion may be one of the countermeasures to prevent DEA-related PM. With regard to PCI technique, Okamura et al (21) reported that a distal protection device was useful for the reduction of HITS in patients with AMI. Although there have been no reports demonstrating the prevention of PM in patients with stable CAD using these devices, their use according to the extent and/or length of DEA may be another option to prevent DEA-related PM.
There were several limitations in the present study. First, our study population was small, which may have affected the results, particularly the logistic regression analysis. Second, we excluded stable CAD patients with several clinical features, including complex lesions. In addition, IVUS and Doppler flow studies were not always performed during PCI because these devices did not consistently cross the target lesion. Therefore, our results may not account for all patients who received elective PCI. Third, the presence of positive remodeling and DEA on IVUS, which were the final associated factors as per the logistic regression analysis, tended to be correlated in the present study. This correlation may contribute to the results of the logistic regression analysis; however, the multicollinearity was not recognized between them and we adopted them in the logistic regression analysis. Forth, the external CSA was slightly lower in the PM group than in the non-PM group, although the frequency of positive remodeling was higher in the PM group. It was difficult to measure the external CSA in some of the patients with extensive DEA identified on IVUS because the EEM circumference and area could not be measured due to acoustic shadowing. In addition, the external CSA and lumen CSA data were shown for the most minimal lesion; however, DEA was not always present at the most minimal lesion. These factors may contribute to the discrepancy between the presence of positive remodeling and low external CSA in the PM group. Fifth, CFR after PCI was assessed only in some of the patients because of a break in the Doppler guidewire. Sixth, the subjective factor of individual physician decision contributed to duration of hospitalization. This was because the decision for discharge was not determined by the PCI protocol but it was dependent on physician judgment. Finally, the definition of PM remains controversial. According to our definition of PM, the cTnT level, even in the PM group, was not particular high, and in the present study, there was no significant difference in the occurrence of cardiovascular events after PCI. However, Prasad et al showed a significant risk of PM in patients with >0.01 ng/mL cTnT (5), and in our opinion, assessing PM in a large number of patients with only a mild elevation in cTnT will provide information on the prognosis.
In conclusion, the presence of DEA identified on IVUS was the significant predictive factor for PM in patients with stable CAD treated by elective PCI. Patients should be carefully screened for DEA by IVUS before PCI, so that adequate measures can be taken for the prevention of PM.
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